These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23987506)

  • 1. Hierarchical scaffolding of an ERK1/2 activation pathway.
    Vetterkind S; Poythress RH; Lin QQ; Morgan KG
    Cell Commun Signal; 2013 Aug; 11():65. PubMed ID: 23987506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IQGAP1 regulates ERK1/2 and AKT signalling in the heart and sustains functional remodelling upon pressure overload.
    Sbroggiò M; Carnevale D; Bertero A; Cifelli G; De Blasio E; Mascio G; Hirsch E; Bahou WF; Turco E; Silengo L; Brancaccio M; Lembo G; Tarone G
    Cardiovasc Res; 2011 Aug; 91(3):456-64. PubMed ID: 21493702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The WW domain of the scaffolding protein IQGAP1 is neither necessary nor sufficient for binding to the MAPKs ERK1 and ERK2.
    Bardwell AJ; Lagunes L; Zebarjedi R; Bardwell L
    J Biol Chem; 2017 May; 292(21):8750-8761. PubMed ID: 28396345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IQGAP1 is an oncogenic target in canine melanoma.
    Lee BH; Neela PH; Kent MS; Zehnder AM
    PLoS One; 2017; 12(4):e0176370. PubMed ID: 28445541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ras GTPase-activating-like protein IQGAP1 is downregulated in human diabetic nephropathy and associated with ERK1/2 pathway activation.
    Zhou H; Yao C; Bian A; Qian J; Zhao X; Zhao Y; Wang W; Xing C
    Mol Cell Biochem; 2014 Jun; 391(1-2):21-5. PubMed ID: 24488174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholecystokinin stimulates extracellular signal-regulated kinase through activation of the epidermal growth factor receptor, Yes, and protein kinase C. Signal amplification at the level of Raf by activation of protein kinase Cepsilon.
    Piiper A; Elez R; You SJ; Kronenberger B; Loitsch S; Roche S; Zeuzem S
    J Biol Chem; 2003 Feb; 278(9):7065-72. PubMed ID: 12496267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mechanism of ERK1/2 regulation in smooth muscle involving acetylation of the ERK1/2 scaffold IQGAP1.
    Vetterkind S; Lin QQ; Morgan KG
    Sci Rep; 2017 Aug; 7(1):9302. PubMed ID: 28839270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulus-specific activation and actin dependency of distinct, spatially separated ERK1/2 fractions in A7r5 smooth muscle cells.
    Vetterkind S; Saphirstein RJ; Morgan KG
    PLoS One; 2012; 7(2):e30409. PubMed ID: 22363435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IQGAP1 binds ERK2 and modulates its activity.
    Roy M; Li Z; Sacks DB
    J Biol Chem; 2004 Apr; 279(17):17329-37. PubMed ID: 14970219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IQGAP1 is a scaffold for mitogen-activated protein kinase signaling.
    Roy M; Li Z; Sacks DB
    Mol Cell Biol; 2005 Sep; 25(18):7940-52. PubMed ID: 16135787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IQGAP1 mediates angiotensin II-induced apoptosis of podocytes via the ERK1/2 MAPK signaling pathway.
    Liu Y; Liang W; Yang Q; Ren Z; Chen X; Zha D; Singhal PC; Ding G
    Am J Nephrol; 2013; 38(5):430-44. PubMed ID: 24247724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flagellin and lipopolysaccharide stimulate the MEK-ERK signaling pathway in chicken heterophils through differential activation of the small GTPases, Ras and Rap1.
    Kogut MH; Genovese KJ; He H
    Mol Immunol; 2007 Mar; 44(7):1729-36. PubMed ID: 17045653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein farnesylation-dependent Raf/extracellular signal-related kinase signaling links to cytoskeletal remodeling to facilitate glucose-induced insulin secretion in pancreatic beta-cells.
    Kowluru A; Veluthakal R; Rhodes CJ; Kamath V; Syed I; Koch BJ
    Diabetes; 2010 Apr; 59(4):967-77. PubMed ID: 20071600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quercetin suppresses the proliferation of multiple myeloma cells by down-regulating IQ motif-containing GTPase activating protein 1 expression and extracellular signal-regulated kinase activation.
    Ma Y; Jin Z; Huang J; Zhou S; Ye H; Jiang S; Yu K
    Leuk Lymphoma; 2014 Nov; 55(11):2597-604. PubMed ID: 24397597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling, leading to actin binding, Elk-1/estrogen receptor transcriptional activation, and ovarian cancer progression.
    Bourguignon LY; Gilad E; Rothman K; Peyrollier K
    J Biol Chem; 2005 Mar; 280(12):11961-72. PubMed ID: 15655247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elastin peptides activate extracellular signal-regulated kinase 1/2 via a Ras-independent mechanism requiring both p110gamma/Raf-1 and protein kinase A/B-Raf signaling in human skin fibroblasts.
    Duca L; Lambert E; Debret R; Rothhut B; Blanchevoye C; Delacoux F; Hornebeck W; Martiny L; Debelle L
    Mol Pharmacol; 2005 Apr; 67(4):1315-24. PubMed ID: 15653554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IQGAP1 selectively interacts with K-Ras but not with H-Ras and modulates K-Ras function.
    Matsunaga H; Kubota K; Inoue T; Isono F; Ando O
    Biochem Biophys Res Commun; 2014 Feb; 444(3):360-4. PubMed ID: 24462863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caveolin-1 orchestrates fibroblast growth factor 2 signaling control of angiogenesis in placental artery endothelial cell caveolae.
    Feng L; Liao WX; Luo Q; Zhang HH; Wang W; Zheng J; Chen DB
    J Cell Physiol; 2012 Jun; 227(6):2480-91. PubMed ID: 21830216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small interfering RNA-mediated down-regulation of caveolin-1 differentially modulates signaling pathways in endothelial cells.
    Gonzalez E; Nagiel A; Lin AJ; Golan DE; Michel T
    J Biol Chem; 2004 Sep; 279(39):40659-69. PubMed ID: 15292187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IQGAP1 scaffold-kinase interaction blockade selectively targets RAS-MAP kinase-driven tumors.
    Jameson KL; Mazur PK; Zehnder AM; Zhang J; Zarnegar B; Sage J; Khavari PA
    Nat Med; 2013 May; 19(5):626-630. PubMed ID: 23603816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.